Literature DB >> 2208769

Spinal muscular atrophy type I combined with atrial septal defect in three sibs.

P Møller1, N Moe, O D Saugstad, K Skullerud, M Velken, K Berg, S Nitter-Hauge, A L Børresen.   

Abstract

All three children of an unrelated Norwegian couple were born with spinal muscular atrophy (SMA I) as confirmed by autopsy in two of them. Two of the children died at birth, whereas one lived for 7 weeks on support systems that included artificial ventilation. All three children had large atrial septal defects (ASD). One had valvular aortic stenosis. Another had arrhinencephaly and transient pleural effusion which was evacuated during pregnancy. The findings may reflect concurrence of unrelated disorders caused by genetic or environmental factors, segregation of linked genes, pleiotropism or the existence of a previously unknown disease.

Entities:  

Mesh:

Year:  1990        PMID: 2208769     DOI: 10.1111/j.1399-0004.1990.tb03553.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  12 in total

1.  Spinal muscle atrophy type 1 (Werdnig-Hoffman disease) with complex cardiac malformation.

Authors:  Wael El-Matary; Sunanda Kotagiri; Duncan Cameron; Ian Peart
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy.

Authors:  Laurent P Bogdanik; Melissa A Osborne; Crystal Davis; Whitney P Martin; Andrew Austin; Frank Rigo; C Frank Bennett; Cathleen M Lutz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

4.  Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.

Authors:  Christopher R Heier; Rosalba Satta; Cathleen Lutz; Christine J DiDonato
Journal:  Hum Mol Genet       Date:  2010-08-06       Impact factor: 6.150

Review 5.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

6.  SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain.

Authors:  Michael P Walker; T K Rajendra; Luciano Saieva; Jennifer L Fuentes; Livio Pellizzoni; A Gregory Matera
Journal:  Hum Mol Genet       Date:  2008-08-08       Impact factor: 6.150

Review 7.  Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies.

Authors:  Raffaella Adami; Daniele Bottai
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

8.  Developmental and degenerative cardiac defects in the Taiwanese mouse model of severe spinal muscular atrophy.

Authors:  Gillian K Maxwell; Eva Szunyogova; Hannah K Shorrock; Thomas H Gillingwater; Simon H Parson
Journal:  J Anat       Date:  2018-02-22       Impact factor: 2.610

Review 9.  ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets.

Authors:  Emmanuelle Coque; Cédric Raoul; Mélissa Bowerman
Journal:  Front Neurosci       Date:  2014-08-28       Impact factor: 4.677

10.  Differential induction of muscle atrophy pathways in two mouse models of spinal muscular atrophy.

Authors:  Marc-Olivier Deguise; Justin G Boyer; Emily R McFall; Armin Yazdani; Yves De Repentigny; Rashmi Kothary
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.